LINCOMYCIN- lincomycin injection

Země: Spojené státy

Jazyk: angličtina

Zdroj: NLM (National Library of Medicine)

Aktivní složka:

LINCOMYCIN HYDROCHLORIDE (UNII: M6T05Z2B68) (LINCOMYCIN - UNII:BOD072YW0F)

Dostupné s:

Sparhawk Laboratories, Inc.

Podání:

INTRAMUSCULAR

Druh předpisu:

PRESCRIPTION

Terapeutické indikace:

300 mg/mL  STERILE LINCOMYCIN INJECTION Caution:Federal law restricts this drug to use by or on the order of a licenced veterinarian.  SWINE ANTIBIOTIC Indicated for the treatment of arthritis caused by susceptible ortanisims and for mycoplasma pneumonia. Lincomycin Injectable contains lincomycin hydrochloride, an antibiotic produced bySteptomyces lincolnensis var. lincolnensis , which is chemically distinct from all other clinically avaialbel antibiotics and is isolated as a white crystalline solid Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for Use in Humans Keep out of reach of children INDICATIONS FOR SWINE Lincomycin injectable is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci,Erysipelothrix and  Mycoplasma spp. As with all drugs, the use of Lincomycin Inje

Přehled produktů:

Lincomycin Injectable is available in three concentrations: 300 mg/mL, 100 mg/mL and 25 mg/mL 300 mg/mL : For use in swine weighing 300 pounds or more. Each mL contains lincomycin hydrochloride equivalent to lincomycin, 300 mg, also Benzyl Alcohol, 9.45 mg added as preservative. Supplied in 100 mL vials. 100 mg/mL : Each mL contains lincomycin hydrochloride equivalent to lincomycin, 100 mg; also Benzyl Alcohol, 9,45 mg added as preservative. Supplied in 100 mL vials. 25 mg/mL : Special baby pig concentration. Each mL contains lincomycin hydrochloride equivalent to lincomycin, 25 mg; also Benyl Alcohol, 9.45 mg added as preservative. Supplied in 100 mL vials.

Stav Autorizace:

Abbreviated New Animal Drug Application

Charakteristika produktu

LINCOMYCIN - LINCOMYCIN INJECTION
SPARHAWK LABORATORIES, INC.
----------
LINCOMYCIN 300 INJECTION
300 MG/ML
STERILE LINCOMYCIN INJECTION
CAUTION:FEDERAL LAW RESTRICTS THIS DRUG TO USE BY OR ON THE ORDER OF A
LICENCED VETERINARIAN.
SWINE ANTIBIOTIC
INDICATED FOR THE TREATMENT OF ARTHRITIS CAUSED BY SUSCEPTIBLE
ORTANISIMS AND
FOR MYCOPLASMA PNEUMONIA.
Lincomycin Injectable contains lincomycin hydrochloride, an antibiotic
produced
by_Steptomyces lincolnensis var. lincolnensis_, which is chemically
distinct from all other
clinically avaialbel antibiotics and is isolated as a white
crystalline solid
Caution: Federal law restricts this drug to use by or on the order of
a licensed
veterinarian.
Not for Use in Humans
Keep out of reach of children
INDICATIONS FOR SWINE
Lincomycin injectable is indicated for the treatment of infectious
forms of arthritis
caused by organisms sensitive to its activity. This includes most of
the organisms
responsible for the various infectious arthritides in swine, such as
staphylococci,
streptococci,_Erysipelothrix_ and _Mycoplasma spp._
CONTRAINDICATIONS
As with all drugs, the use of Lincomycin Injectable is contraindicated
in animals
previously found to be hypersensitive to the drug.
WARNING
Swine intended for human consumption should not be slaughtered within
48 hours of
latest treatment. NOT FOR HUMAN USE.
CAUTION
If no improvement is noted within 48 hours, consult a veterinarian.
ADVERSE REACTIONS
The intramuscular administration to swine may cause a transient
diarrhea or loose
stools. Although this effect had rarely been reported, one must be
alert to the possibility
that it may occur. Should this occur, it is important that the
necessary steps be taken to
prevent the effects of dehydration.
CONTACT INFORMATION
To report suspected adverse events, for technical assistance or to
obtain a copy of the
Safety Data Sheet, contact Sparhawk Laboratories Inc at 1-800-255-6388
or 1-913-888-
7500. For additional information about adverse drug experience
reporting for animal
drugs, contact FDA at